CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : New Jersey
Advanced Search
Select up to three search categories and corresponding keywords using the fields to the right. Refer to the Help section for more detailed instructions.

Search our Collections & Repository

All these words:

For very narrow results

This exact word or phrase:

When looking for a specific result

Any of these words:

Best used for discovery & interchangable words

None of these words:

Recommended to be used in conjunction with other fields

Language:

Dates

Publication Date Range:

to

Document Data

Title:

Document Type:

Library

Collection:

Series:

People

Author:

Help
Clear All

Add terms to the query box

Query box

Help
Clear All
i

CDC’s Investments to Combat Antibiotic Resistance Threats Nationwide : New Jersey

Filetype[PDF-467.41 KB]


  • English

  • Details:

    • Description:
      $930,782 Funding for AR Activities Fiscal Year 2017 Candida auris, a resistant fungus that can cause deadly infections, was identified in New Jersey. CDC provides resources to identify and contain resistant infections, like C. auris. After it emerged in the U.S. in 2016, the AR Lab Network regional labs began providing specialized testing to states fighting new threats. Funding to local health departments: $579,853 - RAPID DETECTION & RESPONSE to emerging drug-resistant germs is critical to contain the spread of these infections.With 2016 funding, New Jersey developed a universal transfer form, to be included in patients’ medical records when transferred between healthcare facilities. Use of this form improves communication between facilities to help ensure that prevention and control measures are continuously maintained, thus preventing the spread of multidrug-resistant organisms $98,000 -  HAI/AR PREVENTION works best when public health and healthcare facilities partner together to implement targeted, coordinated strategies to stop infections and improve antibiotic use. New Jersey received funding for this activity for the first time in 2017 to better prevent infections and protect patients. $54,263 - FOOD SAFETY projects protect communities by rapidly identifying drug-resistant foodborne bacteria to stop and solve outbreaks and improve prevention. In Fiscal Year 2018, New Jersey will ramp up testing to include whole genome sequencing of all Listeria, Salmonella, Campylobacter and E. coli isolates and simultaneously monitor these isolates for resistance genes. States upload the sequence data into PulseNet for nationwide monitoring of outbreaks and trends. When outbreaks are detected, local CDC-supported epidemiologists investigate the cases to stop spread.      Funding to Universities and healthcare partners: $150,000 - RUTGERS, THE STATE UNIVERSITY OF NEW JERSEY: Innovative Prevention & Tracking. Researchers will validate a new rapid diagnostic platform to detect the multidrug resistant fungal pathogen C. auris, and they will analyze C. auris transmission patterns in healthcare facilities by applying advanced genetic fingerprint methods. $48,666 - CENTER FOR DISEASE DYNAMICS, ECONOMICS & POLICY: Innovative Prevention & Tracking. Investigators are working with CDC to gather data on global challenges and opportunities to combat antibiotic resistance and improve antibiotic use, including assisting in global partner engagement. Publication date from document properties. New-Jersey-2017-CDC-AR-Investments.pdf
    • Place as Subject:
    • Main Document Checksum:
    • File Type:

    Supporting Files

    • No Additional Files

    More +

    Related Documents

    You May Also Like

    Checkout today's featured content at stacks.cdc.gov